B&G Foods (BGS) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 net sales declined 5.3% year-over-year to $444.6 million, primarily due to the Green Giant U.S. shelf-stable divestiture and lower unit volumes.
Net income for Q2 2024 was $3.9 million, down from $10.6 million in Q2 2023; adjusted net income was $6.6 million, both down year-over-year.
Adjusted EBITDA for Q2 2024 was $63.9 million, down from $68.5 million in Q2 2023; margin was 14.4% of net sales.
The company reorganized into four business segments in 2024: Specialty, Meals, Frozen & Vegetables, and Spices & Flavor Solutions.
Completed major refinancing, extending debt maturities and reducing balance sheet risk.
Financial highlights
Q2 2024 adjusted gross profit was $93.2 million (21% of net sales), down from $102.7 million (21.9%) in Q2 2023.
Operating income for Q2 2024 was $43.8 million (9.9% margin), down from $49.2 million (10.5%) in Q2 2023.
Net interest expense increased to $37.8 million in Q2 2024 due to higher rates, despite lower average debt.
Cash flow from operations for the first half of 2024 was $46.4 million, down from $132.4 million in the prior year period.
Dividends paid in the first half of 2024 totaled $30.0 million; annual dividend rate is $0.76 per share.
Outlook and guidance
FY 2024 guidance revised: net sales $1.945–$1.97 billion, adjusted EBITDA $300–$315 million, adjusted EPS $0.70–$0.90.
Second half 2024 base business net sales expected to range from -2% to +0.5% year-over-year.
Full-year net interest expense projected at $150–$155 million; CapEx at $30–$35 million.
Management expects certain raw material and freight costs to remain elevated for the remainder of 2024, with most key commodity prices locked in.
The company continues to evaluate strategic divestitures, including a possible sale of some or all assets in the Frozen & Vegetables segment.
Latest events from B&G Foods
- Portfolio transformation and divestitures drive margin gains and lower leverage for 2026.BGS
Q4 20253 Mar 2026 - Portfolio reshaping and operational improvements target margin recovery and 2024 growth.BGS
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - Q3 2024 sales and EBITDA declined, but net income turned positive; outlook remains cautious.BGS
Q3 202416 Jan 2026 - Portfolio streamlining and cost initiatives aim to boost margins and enable future growth.BGS
Barclays 18th Annual Global Consumer Staples Conference 202531 Dec 2025 - Sequential improvement, strong spices growth, and major impairments shape 2025 outlook.BGS
Q4 202418 Dec 2025 - Shelf registration allows up to $800M in securities for growth, debt, and acquisitions.BGS
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG and governance.BGS
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification up for virtual shareholder vote.BGS
Proxy Filing1 Dec 2025 - Q1 2025 sales dropped 10.5% and EBITDA fell 21.2%, prompting lower guidance and cost cuts.BGS
Q1 202525 Nov 2025